Abiomed (NSDQ:ABMD) today said it appointed Charles Simonton as VP and chief medical officer. Simonton most recently served as chief medical officer and divisional VP of global medical affairs at Abbott Vascular where he led programs that resulted in FDA approval of carotid stents, MitraClip and Absorb BVS. He has also spent almost 30 years as […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Medtronic lands CE Mark for Micra AV transcatheter pacing system
Medtronic (NYSE:MDT) announced today that it received CE Mark approval in Europe for its Micra AV transcatheter pacing system (TPS). The Fridley, Minn.-based medtech giant touts its Micra AV as the world’s smallest pacemaker with atrioventricular (AV) synchrony. The system is indicated for treating patients with AV block, adding to its CE Mark-approved leadless pacemaker portfolio. […]
Okami Medical raises $7.2m to support vascular occlusion system
Months after the first use of its LOBO vascular occlusion system on patients, Okami Medical has raised more than $7.2 million. The Aliso Viejo, Calif.–based company raised the money from 18 investors, according to an SEC Form D filed June 10. After securing FDA clearance in late 2019, Okami Medical announced the first use of […]
Support grows for return of medtech reps to hospitals
Twenty-six more medical and surgical societies and healthcare associations have endorsed guidelines for the safe return of medtech company representatives to healthcare facilities during the coronavirus pandemic. The guidance, released in May by AdvaMed, the Association of periOperative Registered Nurses (AORN) and the American Hospital Association (AHA), builds on the April 17 joint statement by AHA, […]
Cardiovascular Systems announces $125m public offering
Cardiovascular Systems (NSDQ:CSII) announced that it commenced an underwritten public offering of common stock shares worth $125 million. In connection with the offering, Cardiovascular Systems (CSI) expects to grant underwriters a 30-day option to purchase up to an additional 15% of the shares being offered as well. All shares will be sold by CSI, according to […]
Medical societies issue ‘urgent letter’ on racial violence
A trio of medical societies issued an urgent letter to denounce the racism and violence unfolding in the wake of George Floyd’s death in police custody. The letter, dated May 30 (five days after Floyd was killed in Minneapolis), was issued by the Association of Black Cardiologists and its cardiovascular partners, the American Heart Association […]
Study: TAVR considered safe treatment for bicuspid valve disease
A recent study has shown that transcatheter aortic valve replacement (TAVR) is a safe treatment option for people who need a bicuspid aortic valve replacement. The study found that patients who were at an increased risk for surgery had a 30-day and one-year mortality rate and stroke rate similar to patients with more common tricuspid […]
Edwards Lifesciences wins approval in China for Sapien 3
Edwards Lifesciences (NYSE:EW) announced today that it received regulatory approval in China for its Sapien 3 transcatheter heart valve. Sapien 3 TAVR (transcatheter aortic valve replacement) is used in the treatment of patients suffering from severe, symptomatic aortic stenosis (AS) who are at high risk for or unable to undergo open-heart surgery. According to a news […]
SMT’s TAVR wins CE Mark for aortic stenosis
Sahajanand Medical Technology (SMT) announced today that its Hydra TAVR device has received the CE Mark for the treatment of severe aortic stenosis. The Hydra aortic valve is a self-expandable, nitinol-based, supra annular aortic system with a mechanism for recapturing the valve during deployment, according to Mumbai, India-based SMT. This property helps in precise placement […]
Medtronic lands CE Mark for shorter therapy for high bleeding risk heart patients
Medtronic (NYSE:MDT) announced today that it received CE Mark approval for a one-month indication for high bleeding risk (HBR) patients implanted with the Resolute Onyx. The medtech giant’s indication is for one-month dual antiplatelet therapy (DAPT) in HBR patients implanted with the Resolute Onyx drug-eluting stent (DES). In a news release, the company touted the indication […]
iRhythm Technologies names new chief financial officer
iRhythm Technologies (NSDQ:IRTC) this week said it appointed Douglas Devine as chief financial officer, effective June 22. Devine succeeds Matthew Garrett who announced his intention to step down. Garrett will assist in the transition of CFO responsibilities and will remain at the company under an advisory role for up to a year. “On behalf of everyone […]